BACKGROUND: The prevalence of coronary artery disease (CAD) in Latin America is increasing and contributes importantly to the global burden of cardiovascular diseases. Advanced resources for the diagnosis and treatment of CAD are available in most of the region. However, preventive approaches such as cardiovascular rehabilitation programs (CVRP) may not be widely implemented. METHODS: We carried out a telephone-based survey to hospitals sampled in a random and population-weighted fashion from a list of 202 centers with cardiac catheterization laboratories in Mexico, Central and South America, and the Caribbean. We collected information of availability of cardiac procedures and imaging techniques and also extensive data about the presence, characteristics, and quality measures of CVRP. RESULTS: A total of 98 centers were contacted, and a complete survey was provided by 59 centers (60%) from 13 countries. Cardiovascular rehabilitation programs were available in only 56% of centers. There were no differences between centers with and without CVRP regarding type of hospital, availability of cardiac surgery, and annual volume of patients with myocardial infarction. Among centers with CVRP, 70% offered all phases of CVRP. The lack of CVRP was attributed to lack of qualified personnel in 41% of centers, financial constraints in 33%, and lack of physical space in 13%. All centers without CVRP performed cardiac surgery and percutaneous interventions. CONCLUSIONS: Despite the presence of state-of-the-art technology for the diagnosis and treatment of CAD, availability of CVRP, a less expensive yet effective tool for the treatment of CAD, appears to be limited in Latin America and the Caribbean.
BACKGROUND: The prevalence of coronary artery disease (CAD) in Latin America is increasing and contributes importantly to the global burden of cardiovascular diseases. Advanced resources for the diagnosis and treatment of CAD are available in most of the region. However, preventive approaches such as cardiovascular rehabilitation programs (CVRP) may not be widely implemented. METHODS: We carried out a telephone-based survey to hospitals sampled in a random and population-weighted fashion from a list of 202 centers with cardiac catheterization laboratories in Mexico, Central and South America, and the Caribbean. We collected information of availability of cardiac procedures and imaging techniques and also extensive data about the presence, characteristics, and quality measures of CVRP. RESULTS: A total of 98 centers were contacted, and a complete survey was provided by 59 centers (60%) from 13 countries. Cardiovascular rehabilitation programs were available in only 56% of centers. There were no differences between centers with and without CVRP regarding type of hospital, availability of cardiac surgery, and annual volume of patients with myocardial infarction. Among centers with CVRP, 70% offered all phases of CVRP. The lack of CVRP was attributed to lack of qualified personnel in 41% of centers, financial constraints in 33%, and lack of physical space in 13%. All centers without CVRP performed cardiac surgery and percutaneous interventions. CONCLUSIONS: Despite the presence of state-of-the-art technology for the diagnosis and treatment of CAD, availability of CVRP, a less expensive yet effective tool for the treatment of CAD, appears to be limited in Latin America and the Caribbean.
Authors: Raquel Rodrigues Britto; Marta Supervia; Karam Turk-Adawi; Gabriela Suéllen da Silva Chaves; Ella Pesah; Francisco Lopez-Jimenez; Danielle Aparecida Gomes Pereira; Artur H Herdy; Sherry L Grace Journal: Braz J Phys Ther Date: 2019-03-05 Impact factor: 3.377
Authors: Gabriela Lima de Melo Ghisi; Rafaella Zulianello dos Santos; Eduardo Eugênio Aranha; Alessandra Daros Nunes; Paul Oh; Magnus Benetti; Sherry L Grace Journal: Vasc Health Risk Manag Date: 2013-08-30
Authors: Sherry L Grace; Karam I Turk-Adawi; Aashish Contractor; Alison Atrey; Norm Campbell; Wayne Derman; Gabriela L Melo Ghisi; Neil Oldridge; Bidyut K Sarkar; Tee Joo Yeo; Francisco Lopez-Jimenez; Shanthi Mendis; Paul Oh; Dayi Hu; Nizal Sarrafzadegan Journal: Heart Date: 2016-05-15 Impact factor: 5.994
Authors: Amanda L Hannan; Wayne Hing; Mike Climstein; Jeff S Coombes; James Furness; Rohan Jayasinghe; Joshua Byrnes Journal: Open Access J Sports Med Date: 2018-04-30